Abstract
OBJECTIVES--To analyse whether the intraindividual variability of the bioavailability of oral methotrexate in rheumatoid arthritis (RA) is as high as the interindividual variability and whether the bioavailability testing can be simplified. METHODS--Fifteen mg methotrexate was given orally after an overnight fast to 10 patients with RA on two occasions, one week (n = 4) or two years (n = 6) apart, respectively. Plasma samples were taken at specific time intervals and analysed by fluorescence polarisation immunoassay. The areas under the plasma concentration versus time curves from 0 to infinity (AUC) were calculated after fitting to a two-compartment extravascular model with lag time. RESULTS--The interindividual variability of the AUCs showed a more than five fold range from 77 to 471 min x mumol/l. In contrast, the intraindividual differences of AUCs between the two visits ranged from 3 to 100 min x mumol/l, reflecting a 3-30% change in nine of 10 patients. Close correlations were found between the AUCs and the plasma concentrations with a most pronounced correlation eight hours after methotrexate intake (r = 0.975; p < 0.001). CONCLUSIONS--The high interindividual variability of the AUCs was confirmed. Conversely, only a modest intraindividual variability was disclosed. Plasma sample analysis at a single time point four to eight hours after methotrexate application could simplify estimation of the bioavailability.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ahern M., Booth J., Loxton A., McCarthy P., Meffin P., Kevat S. Methotrexate kinetics in rheumatoid arthritis: is there an interaction with nonsteroidal antiinflammatory drugs? J Rheumatol. 1988 Sep;15(9):1356–1360. [PubMed] [Google Scholar]
- Auvinet B., Jarrier I., Le Levier F., Pegon Y., Turcant A., Allain P. Biodisponibilité comparée du méthotrexate par voies orale et intramusculaire dans la polyarthrite rhumatoïde. Presse Med. 1992 May 2;21(17):822–822. [PubMed] [Google Scholar]
- Bircher J., Küpfer A., Gikalov I., Preisig R. Aminopyrine demethylation measured by breath analysis in cirrhosis. Clin Pharmacol Ther. 1976 Oct;20(4):484–492. doi: 10.1002/cpt1976204484. [DOI] [PubMed] [Google Scholar]
- Campbell N. R., Hasinoff B. B. Iron supplements: a common cause of drug interactions. Br J Clin Pharmacol. 1991 Mar;31(3):251–255. doi: 10.1111/j.1365-2125.1991.tb05525.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Freeman-Narrod M., Gerstley B. J., Engstrom P. F., Bornstein R. S. Comparison of serum concentrations of methotrexate after various routes of administration. Cancer. 1975 Nov;36(5):1619–1624. doi: 10.1002/1097-0142(197511)36:5<1619::aid-cncr2820360514>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
- Kozloski G. D., De Vito J. M., Kisicki J. C., Johnson J. B. The effect of food on the absorption of methotrexate sodium tablets in healthy volunteers. Arthritis Rheum. 1992 Jul;35(7):761–764. doi: 10.1002/art.1780350708. [DOI] [PubMed] [Google Scholar]
- Oguey D., Kölliker F., Gerber N. J., Reichen J. Effect of food on the bioavailability of low-dose methotrexate in patients with rheumatoid arthritis. Arthritis Rheum. 1992 Jun;35(6):611–614. doi: 10.1002/art.1780350603. [DOI] [PubMed] [Google Scholar]
- Pesce M. A., Bodourian S. H. Evaluation of a fluorescence polarization immunoassay procedure for quantitation of methotrexate. Ther Drug Monit. 1986;8(1):115–121. doi: 10.1097/00007691-198603000-00020. [DOI] [PubMed] [Google Scholar]
- Sauvezie B., Dubost J. J., Garandeau A., Rampon S. Le méthotrexate dans la polyarthrite rhumatoïde. Revue de la littérature. Rev Rhum Mal Osteoartic. 1987 Jul-Sep;54(7-9):607–615. [PubMed] [Google Scholar]
- Seideman P. Methotrexate--the relationship between dose and clinical effect. Br J Rheumatol. 1993 Aug;32(8):751–753. doi: 10.1093/rheumatology/32.8.751. [DOI] [PubMed] [Google Scholar]
- Stewart C. F., Evans W. E. Drug-drug interactions with antirheumatic agents: review of selected clinically important interactions. J Rheumatol Suppl. 1990 May;22:16–23. [PubMed] [Google Scholar]
- Tygstrup N. Determination of the hepatic elimination capacity (Lm) of galactose by single injection. Scand J Clin Lab Invest Suppl. 1966;18:118–125. [PubMed] [Google Scholar]